A. Drelichman

发表

The effects of cyclophosphamide, ketoconazole, aclacinomycin‐A, methotrexate, and scheduled methotrexate‐5‐fluorouracil combination chemotherapy on the transplantable R‐3327 prostatic adenocarcinoma in the F1 hybrid male rat

James B. Smith, P. Ghayad, C. Dhabuwala, 1985, Cancer.

Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil

P. McLaughlin, D. Pieper, C. Lobocki, 1997, Cancer Chemotherapy and Pharmacology.

Squamous Cell Carcinoma of the Head and Neck

J. Jacobs, J. Kinzie, D. Decker, 2006 .

Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma

V. Vaitkevicius, J. Muz, D. Decker, 1984, Cancer.

Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.

V. Ratanatharathorn, M. al-Sarraf, A. Drelichman, 1982, American journal of clinical oncology.

Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes.

S. Dakhil, C. Ryan, E. Crawford, 2008, Clinical genitourinary cancer.

IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents

H. Ghazal, N. Gabrail, A. Mangione, 2011 .

A randomized trial of the combination of cis‐platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck

M. al-Sarraf, A. Drelichman, G. Cummings, 1983, Cancer.

Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.

C. Osborne, D. V. Von Hoff, E. Crawford, 1983, Cancer treatment reports.

Chemotherapy for nasopharyngeal carcinoma a ten‐year experience

J. Crissman, D. Decker, M. al-Sarraf, 1983, Cancer.

Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.

J. Jacobs, J. Kinzie, J. Kish, 1982, Cancer treatment reports.

Carcinoma of prostate metastatic to breast.

V. Vaitkevicius, E. Pontes, M. al-Sarraf, 1980, Urology.

Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.

P. Ghayad, C. Dhabuwala, A. Drelichman, 1987, Urology.

Evaluation of cyclophosphamide, adriamycin, and cis‐platinum (CAP) in patients with disseminated prostatic carcinoma: A phase II study

M. al-Sarraf, A. Drelichman, J. Oldford, 1985, American journal of clinical oncology.

Phase II study of hexamethylmelamine for disseminated prostatic carcinoma.

M. al-Sarraf, A. Drelichman, R. Brownlee, 1981, Cancer clinical trials.

Adjuvant chemotherapy with high dose bolus Cis-diamminodichloroplatinum II (CDD) and 120 hour infusion 5-fluorouracil (5-FU) in stage III and IV squamous cell carcinoma of the head and neck

D. Decker, A. Drelichman, J. Jacobs, 1982 .

cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck.

J. Jacobs, J. Kinzie, A. Weaver, 1982, Head & neck surgery.

Leiomyosarcoma of scrotum--case report and review of literature.

D. Portenier, A. Drelichman, D. Mehregan, 2006, Urology.

Phase II study of nafoxidine in the therapy for advanced renal carcinoma.

V. Vaitkevicius, L. Feun, A. Singhakowinta, 1979, Cancer treatment reports.

Ureteral obstruction secondary to metastatic breast carcinoma

V. Vaitkevicius, L. Feun, A. Singhakowinta, 1979, Cancer.

Phase II evaluation of aclacinomyin‐A (NSC‐208734) in adenocarcinoma of the kidney

D. Decker, M. al-Sarraf, A. Drelichman, 1984, American journal of clinical oncology.